Quantcast
Last updated on April 16, 2014 at 11:16 EDT

Latest Substantia nigra Stories

2014-04-04 12:27:48

DUBLIN, Apr. 04, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/sbjkkl/deep_brain ) has announced the addition of the "Deep Brain Stimulation Devices Market for Parkinson's Disease - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) A rise in ageing population has been found to be the major causative factor for development of Parkinson's...

2013-10-23 12:29:31

LA JOLLA, Calif., Oct. 23, 2013 /PRNewswire/ -- "Stem cell therapy is an enthralling new achievement for the management of Parkinson's disease," said Dr. Stacy, the Vice Dean for Clinical Research, Neurology at Duke University School of Medicine. According to the Michael J. Fox Foundation, Parkinson's disease in the U.S. alone affects one in 100 people over 60 and 60,000 new cases will be diagnosed this year. Additionally, today's best Parkinson's drug was discovered in 1967. Fast...

2013-10-16 08:28:21

TACOMA, Wash., Oct. 16, 2013 /PRNewswire/ -- A paper published in the Journal of Neuroimmune Pharmacology shows that Revalesio's novel therapeutic RNS60 significantly improved biochemical and behavioral (movement) outcomes in a mouse model of Parkinson's disease (PD). The research was conducted by the laboratory of Dr. Kalipada Pahan at Rush University Medical Center. The model used in the study generates Parkinson's-like symptoms through targeting dopaminergic neurons in the...

2013-08-21 13:13:10

Finding offers clue to developing treatments for misuse of illicit drugs Scientists today reported a possible basis for why food-restricted animals show increased susceptibility to drugs of abuse. This association has puzzled researchers since it was first observed more than three decades ago. Senior author Michael Beckstead, Ph.D., from the School of Medicine at The University of Texas Health Science Center San Antonio, said the team found that dopamine neurons in a brain region called...

2013-01-09 08:27:04

SUNNYVALE, Calif., Jan. 9, 2013 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with protein misfolding and apoptosis centered around its patented therapeutic protein Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF), today presented positive preclinical efficacy data for MANF in a neurorestoration 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease. The data...

2013-01-04 11:08:34

Study suggests potential new target in fight against debilitating disease For several years, neurologists at UCLA have been building a case that a link exists between pesticides and Parkinson's disease. To date, paraquat, maneb and ziram – common chemicals sprayed in California's Central Valley and elsewhere – have been tied to increases in the disease, not only among farmworkers but in individuals who simply lived or worked near fields and likely inhaled drifting particles....

2012-11-27 13:58:22

New MRI technique could help doctors track how patients respond to treatment A new imaging technique developed at MIT offers the first glimpse of the degeneration of two brain structures affected by Parkinson's disease. The technique, which combines several types of magnetic resonance imaging (MRI), could allow doctors to better monitor patients' progression and track the effectiveness of potential new treatments, says Suzanne Corkin, MIT professor emerita of neuroscience and leader of...

2012-11-27 08:27:42

SUNNYVALE, Calif., Nov. 27, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (OTCQB: AMBS), a biotechnology company developing new disease-modifying treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced that the Company has successfully completed experiments demonstrating that MANF has an excellent diffusion profile in the striatum of rat brains. The striatum is located in the brain,...

2012-11-16 11:06:17

Transmission model shows two main hallmarks of Parkinson´s disease - death of dopamine neurons and disease protein clumps Understanding how any disease progresses is one of the first and most important steps towards finding treatments to stop it. This has been the case for such brain-degenerating conditions as Alzheimer's disease. Now, after several years of incremental study, researchers at the Perelman School of Medicine, University of Pennsylvania have been able to piece together...

2012-10-25 07:32:07

SUNNYVALE, Calif., Oct. 25, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (OTCQB: AMBS), a biotechnology company developing new disease-modifying treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centred on its proprietary anti-apoptosis therapeutic protein MANF, today announced that the Company has received positive behavioural efficacy data for MANF in a neurorestoration 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease. The data shows superiority of...